Compound Libraries

A unique collection of 2540 compounds targeting CNS signaling for high throughput screening (HTS) and high content screening (HCS) for new drugs;

A unique collection of 1660 neurotransmitter receptor compounds, can be used for HTS and HCS screening；

A unique collection of 2154 compounds related to neurodegenerative diseases can be used for HTS or HCS；

A unique collection of 193 bioactive compounds specifically targeting adrenergic receptors, effective tool for screening new drugs or new target identification;

A unique collection of 268 compounds targeting serotonin receptors for high throughput screening and high content screening;

1264 small molecule compounds with pro-oxidant or anti-oxidant activity for high-throughput and high-content screening.

A unique collection of 101 compounds with defined hematopoietic toxicity for high throughput and high content drug screening;

A unique collection of 1248 compounds with defined autophagy-inducing or -inhibitory activity for research in autophagy, high throughput screening (HTS) and high content screening (HCS) for new drugs;

A unique collection of 188 compounds targeting histaminergic receptor and melatonin receptor for high throughput screening (HTS) and high content screening (HCS) for new drugs;